Literature DB >> 18520986

Botulinum toxin: treatment of self-mutilation in patients with Lesch-Nyhan syndrome.

Cristiam Gutierrez1, Alejandro Pellene, Federico Micheli.   

Abstract

Lesch-Nyhan syndrome (LNS) is a rare X-linked recessive disorder involving purine metabolism caused by the congenital absence of hypoxanthine guanine phosphoribosyl transferase. A characteristic feature of LNS is the appearance of intractable self-injurious behavior, usually in the form of severe lip and finger biting. The mechanism behind this severe self-mutilating behavior is unknown, and is one of the main challenges in the management of this condition. We here report the case of a 30-year-old man with a confirmed diagnosis of LNS who was successfully treated for self-mutilation of his lips with repeated botulinum toxin A (BTX-A) injections in the facial perioral muscles. Our findings suggest that treatment with BTX-A helped reduce self-abusive behavior in this patient. Our case illustrates that BTX-A injections can be a useful therapeutic approach in patients with self-abusive behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520986     DOI: 10.1097/WNF.0b013e31814a62cc

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  3 in total

1.  Self-mutilation of tongue and lip in a patient with simple schizophrenia.

Authors:  Maria Cristina Munerato; Sabrina Pozatti Moure; Vivian Machado; Fernando Grilo Gomes
Journal:  Clin Med Res       Date:  2010-09-17

Review 2.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

3.  A modified intraoral resin mouthguard to prevent self-mutilations in lesch-nyhan patients.

Authors:  Giulia Ragazzini; Alessia Delucchi; Enrico Calcagno; Roberto Servetto; Gloria Denotti
Journal:  Int J Dent       Date:  2014-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.